These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 9589471)
1. Expression of KAI1 in paraffin-embedded normal, hyperplastic and neoplastic prostate and prostate carcinoma cell lines. Ward JM; Konishi N; Ohshima M; Lamb PW; Jorcyk CL; Barrett JC Pathol Int; 1998 Feb; 48(2):87-92. PubMed ID: 9589471 [TBL] [Abstract][Full Text] [Related]
2. Expression of the KAI1 protein in benign prostatic hyperplasia and prostate cancer. Ueda T; Ichikawa T; Tamaru J; Mikata A; Akakura K; Akimoto S; Imai T; Yoshie O; Shiraishi T; Yatani R; Ito H; Shimazaki J Am J Pathol; 1996 Nov; 149(5):1435-40. PubMed ID: 8909232 [TBL] [Abstract][Full Text] [Related]
3. KAI1/CD82 protein expression in primary prostate cancer and in BPH associated with cancer. Lijovic M; Somers G; Frauman AG Cancer Detect Prev; 2002; 26(1):69-77. PubMed ID: 12088206 [TBL] [Abstract][Full Text] [Related]
4. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells. De Marzo AM; Meeker AK; Epstein JI; Coffey DS Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039 [TBL] [Abstract][Full Text] [Related]
5. Expression of estrogen receptor-B ( ER-B ) in bengin and malignant prostatic epithelial cells and its correlation with the clinico-pathological features. Gabal SM; Habib FM; Helmy DO; Ibrahim MF J Egypt Natl Canc Inst; 2007 Dec; 19(4):239-48. PubMed ID: 19672287 [TBL] [Abstract][Full Text] [Related]
6. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Dong JT; Suzuki H; Pin SS; Bova GS; Schalken JA; Isaacs WB; Barrett JC; Isaacs JT Cancer Res; 1996 Oct; 56(19):4387-90. PubMed ID: 8813131 [TBL] [Abstract][Full Text] [Related]
7. Identification of the rat homologue of KAI1 and its expression in Dunning rat prostate cancers. Suzuki H; Dong JT; Gao AC; Barrett JC; Isaacs JT Prostate; 1998 Dec; 37(4):253-60. PubMed ID: 9831222 [TBL] [Abstract][Full Text] [Related]
8. Expression of the prostate cancer metastasis suppressor gene KAI1 in primary prostate cancers: a biphasic relationship with tumour grade. Bouras T; Frauman AG J Pathol; 1999 Aug; 188(4):382-8. PubMed ID: 10440748 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of c-erbB-2 protein in human benign and neoplastic prostate. Ware JL; Maygarden SJ; Koontz WW; Strom SC Hum Pathol; 1991 Mar; 22(3):254-8. PubMed ID: 1672281 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of retinoblastoma and p53 tumor suppressor genes in prostatic intraepithelial neoplasia: comparison with prostatic adenocarcinoma and benign prostate. Tamboli P; Amin MB; Xu HJ; Linden MD Mod Pathol; 1998 Mar; 11(3):247-52. PubMed ID: 9521470 [TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression. Wu GJ; Wu MW; Wang SW; Liu Z; Qu P; Peng Q; Yang H; Varma VA; Sun QC; Petros JA; Lim SD; Amin MB Gene; 2001 Nov; 279(1):17-31. PubMed ID: 11722842 [TBL] [Abstract][Full Text] [Related]
12. Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues. Hahn D; Simak R; Steiner GE; Handisurya A; Susani M; Marberger M J Urol; 2000 Aug; 164(2):506-10. PubMed ID: 10893635 [TBL] [Abstract][Full Text] [Related]
13. Expression of a human cell adhesion molecule, MUC18, in prostate cancer cell lines and tissues. Wu GJ; Varma VA; Wu MW; Wang SW; Qu P; Yang H; Petros JA; Lim SD; Amin MB Prostate; 2001 Sep; 48(4):305-15. PubMed ID: 11536311 [TBL] [Abstract][Full Text] [Related]
14. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases. Bostwick DG; Pacelli A; Blute M; Roche P; Murphy GP Cancer; 1998 Jun; 82(11):2256-61. PubMed ID: 9610707 [TBL] [Abstract][Full Text] [Related]
15. The pattern of CD10 expression in selected pathologic entities of the prostate gland. Tawfic S; Niehans GA; Manivel JC Hum Pathol; 2003 May; 34(5):450-6. PubMed ID: 12792918 [TBL] [Abstract][Full Text] [Related]
16. Galectin-1 and galectin-3 expression in human prostate tissue and prostate cancer. Ellerhorst J; Troncoso P; Xu XC; Lee J; Lotan R Urol Res; 1999 Oct; 27(5):362-7. PubMed ID: 10550525 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines. Sekita N; Suzuki H; Ichikawa T; Kito H; Akakura K; Igarashi T; Nakayama T; Watanabe M; Shiraishi T; Toyota M; Yoshie O; Ito H Jpn J Cancer Res; 2001 Sep; 92(9):947-51. PubMed ID: 11572762 [TBL] [Abstract][Full Text] [Related]
18. Frequent loss of KAI1 expression in squamous and lymphoid neoplasms. An immunohistochemical study of archival tissues. Geradts J; Maynard R; Birrer MJ; Hendricks D; Abbondanzo SL; Fong KM; Barrett JC; Lombardi DP Am J Pathol; 1999 Jun; 154(6):1665-71. PubMed ID: 10362791 [TBL] [Abstract][Full Text] [Related]
19. KAI1/CD82 gene expression in benign prostatic hyperplasia and late-stage prostate cancer in Chinese. Hu WL; Li YQ; He HX; Li QR; Tian Y; Lai RQ; Mei H Asian J Androl; 2000 Sep; 2(3):221-4. PubMed ID: 11225981 [TBL] [Abstract][Full Text] [Related]
20. Precursor of prostate-specific antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 90 cases. Hull D; Ma J; Singh H; Hossain D; Qian J; Bostwick DG BJU Int; 2009 Oct; 104(7):915-8. PubMed ID: 19388995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]